Skip to main content
Top
Published in: BMC Urology 1/2020

01-12-2020 | Cystitis | Research article

Proteomic analysis of bladder biopsies from interstitial cystitis/bladder pain syndrome patients with and without Hunner’s lesions reveals differences in expression of inflammatory and structural proteins

Published in: BMC Urology | Issue 1/2020

Login to get access

Abstract

Background

Interstitial cystitis/bladder pain syndrome is a bladder disease usually characterized by pain, urgency, and frequency. Interstitial cystitis is currently classified into two subtypes, with and without Hunner’s lesions. However, the underlying etiology of interstitial cystitis and its subtypes are largely unknown.

Methods

To better understand the biological changes in the bladder of interstitial cystitis/bladder pain syndrome patients, we directly analyzed bladder tissue of interstitial cystitis patients, both those with Hunner’s lesions and those without. Proteins in the bladder biopsies were analyzed using nanoscale high-performance liquid chromatography-tandem mass spectrometry. Disease subgroups were compared and significantly expressed proteins were mapped using STRING to determine protein associations and functions.

Results

We found that patients with Hunner’s lesions had significant increases in inflammatory and endoplasmic reticulum stress proteins, with a decrease in cellular adhesive proteins, compared to patients without Hunner’s lesions. These patients also exhibited a decrease in proteins associated with the Rap1 signaling pathway, which regulates cell proliferation and wound healing. When comparing diseased and non-disease-apparent tissue in patients with Hunner’s lesions, diseased tissue exhibited a decrease in ubiquitination proteins.

Conclusions

In summary, there are significant differences in protein expression found in the bladders of interstitial cystitis patients with and without Hunner’s lesions, indicating a disturbance in proteins associated with cellular adhesion, proliferation, protein processing, and wound healing.
Literature
1.
go back to reference Temml C, Wehrberger C, Riedl C, Ponholzer A, Marszalek M, Madersbacher S. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol. 2007;51(3):803–8 (discussion 809).CrossRefPubMed Temml C, Wehrberger C, Riedl C, Ponholzer A, Marszalek M, Madersbacher S. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol. 2007;51(3):803–8 (discussion 809).CrossRefPubMed
2.
go back to reference Parsons JK, Kurth K, Sant GR. Epidemiologic issues in interstitial cystitis. Urology. 2007;69(4 Suppl):5–8.CrossRefPubMed Parsons JK, Kurth K, Sant GR. Epidemiologic issues in interstitial cystitis. Urology. 2007;69(4 Suppl):5–8.CrossRefPubMed
4.
go back to reference Peeker RFM. Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol. 2002;167(6):2470–2.CrossRefPubMed Peeker RFM. Toward a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol. 2002;167(6):2470–2.CrossRefPubMed
5.
go back to reference Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol. 2004;171(4):1554–8.CrossRefPubMed Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol. 2004;171(4):1554–8.CrossRefPubMed
6.
go back to reference Wein AJ, Hanno PM, Gillenwater JY. Interstitial cystitis: an introduction to the problem. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ, editors. Interstitial cystitis. London: Springer; 1990. p. 3–15.CrossRef Wein AJ, Hanno PM, Gillenwater JY. Interstitial cystitis: an introduction to the problem. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ, editors. Interstitial cystitis. London: Springer; 1990. p. 3–15.CrossRef
7.
go back to reference Keay S, Zhang CO, Kagen DI, et al. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol. 1997;158(5):1983–8.CrossRefPubMed Keay S, Zhang CO, Kagen DI, et al. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol. 1997;158(5):1983–8.CrossRefPubMed
8.
go back to reference Keay S, Zhang CO, Shoenfelt JL, Chai TC. Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology. 2003;61(6):1278–84.CrossRefPubMed Keay S, Zhang CO, Shoenfelt JL, Chai TC. Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology. 2003;61(6):1278–84.CrossRefPubMed
9.
go back to reference Maeda D, Akiyama Y, Morikawa T, et al. Hunner-type (classic) interstitial cystitis: A distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation. PLoS ONE. 2015;10(11):e0143316.CrossRefPubMedPubMedCentral Maeda D, Akiyama Y, Morikawa T, et al. Hunner-type (classic) interstitial cystitis: A distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation. PLoS ONE. 2015;10(11):e0143316.CrossRefPubMedPubMedCentral
10.
go back to reference Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P. A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol. 2004;191(1):73–82.CrossRefPubMed Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P. A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol. 2004;191(1):73–82.CrossRefPubMed
11.
go back to reference Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.CrossRefPubMed Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13.CrossRefPubMed
12.
go back to reference Goder V. Roles of ubiquitin in endoplasmic reticulum-associated protein degradation (ERAD). Curr Protein Pept Sci. 2012;13(5):425–35.CrossRefPubMed Goder V. Roles of ubiquitin in endoplasmic reticulum-associated protein degradation (ERAD). Curr Protein Pept Sci. 2012;13(5):425–35.CrossRefPubMed
13.
go back to reference Wu S, Yao M. Advances in the research of mechanism of protein ubiquitination in wound healing. Zhonghua Shao Shang Za Zhi. 2016;32(2):119–21.PubMed Wu S, Yao M. Advances in the research of mechanism of protein ubiquitination in wound healing. Zhonghua Shao Shang Za Zhi. 2016;32(2):119–21.PubMed
14.
go back to reference Huang Q, Figueiredo-Pereira ME. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis. 2010;15(11):1292–311.CrossRefPubMedPubMedCentral Huang Q, Figueiredo-Pereira ME. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis. 2010;15(11):1292–311.CrossRefPubMedPubMedCentral
15.
go back to reference Duh K, Funaro MG, DeGouveia W, et al. Crosstalk between the immune system and neural pathways in interstitial cystitis/bladder pain syndrome. Discov Med. 2018;25(139):243–50.PubMed Duh K, Funaro MG, DeGouveia W, et al. Crosstalk between the immune system and neural pathways in interstitial cystitis/bladder pain syndrome. Discov Med. 2018;25(139):243–50.PubMed
16.
go back to reference Gamper M, Viereck V, Eberhard J, et al. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C. Int Urogynecol J. 2013;24(12):2049–57.CrossRefPubMedPubMedCentral Gamper M, Viereck V, Eberhard J, et al. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C. Int Urogynecol J. 2013;24(12):2049–57.CrossRefPubMedPubMedCentral
17.
go back to reference Shie JH, Liu HT, Kuo HC. Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome. Urology. 2012;79(2):484.e487-413.CrossRef Shie JH, Liu HT, Kuo HC. Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome. Urology. 2012;79(2):484.e487-413.CrossRef
18.
go back to reference Gama MR, Collins CH, Bottoli CB. Nano-liquid chromatography in pharmaceutical and biomedical research. J Chromatogr Sci. 2013;51(7):694–703.CrossRefPubMed Gama MR, Collins CH, Bottoli CB. Nano-liquid chromatography in pharmaceutical and biomedical research. J Chromatogr Sci. 2013;51(7):694–703.CrossRefPubMed
Metadata
Title
Proteomic analysis of bladder biopsies from interstitial cystitis/bladder pain syndrome patients with and without Hunner’s lesions reveals differences in expression of inflammatory and structural proteins
Publication date
01-12-2020
Published in
BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-00751-x

Other articles of this Issue 1/2020

BMC Urology 1/2020 Go to the issue